Bioventus OA Pain Business Returns to Growth Ahead of Schedule
The company grew in the low single digits in the third quarter of 2023 as its OA pain sales volume...
The company grew in the low single digits in the third quarter of 2023 as its OA pain sales volume...
The company's orthopedic sales grew in the mid-teens during the third quarter of 2023, as it continues to win market...
AceConnex is intended for use in soft tissue surgical procedures where constructs are used for reconstruction, replacement or augmentation of...
The company grew in the mid-single-digits in the third quarter of 2023, driven by knee replacement and its SET product...
The company grew more than 50% in the third quarter of 2023 as it benefit from continued share growth and...
The company grew more than 40% in the third quarter of 2023 as it procedural solutions continue winning significant market...
The company grew nearly 29% in the third quarter of 2023, notching its sixth consecutive quarter of record revenues....
Dr. Grant Shifflett believes the indications for spinal fusion will decrease as technology evolves....
The company grew in the high-single-digits in the third quarter of 2023, driven by market recovery and improving operational performance....
The company grew in the mid-single-digits for the third quarter of 2023, driven by new products and better-than-expected orthobiologics sales....
Login
Register for a free account
As a guest member you get access to more articles and videos every month.